Immunotherapy Efforts and Fight CRC

hero symbol

Dr. Michael Morse from Duke University and Fight CRC’s Andi Dwyer discuss the state of the science and clinical care of immunotherapy (IO); giving a glimpse of the contributions of the Fight CRC IO Workgroup.

Watch the Webinar on YouTube

View the Slides on Slideshare

About The Presentors

Dr. Michael Morse

Dr. Michael Morse from Duke UniversityDr. Michael Aaron Morse is studying the use of immune therapies to treat various cancers, including gastrointestinal, breast, and lung cancers and melanoma. These therapies include vaccines based on dendritic cells developed in our laboratory as well as vaccines based on peptides, viral vectors, and DNA plasmids. Our group is also a national leader in the development and use of laboratory assays for demonstrating immunologic responses to cancer vaccines. Finally, we are developing immunotherapies based on adoptive transfer of tumor and viral antigen-specific T cells.

Our current clinical trials include phase I and II studies of immunotherapy for: patients with metastatic malignancies expressing CEA, pancreatic cancer, colorectal cancer, breast cancer, and ovarian cancer, and leukemias following HSCT. My clinical area of expertise is in gastrointestinal oncology, in particular, the treatment of hepatic malignancies, and malignant melanoma.

Education and Training
Fellow In Hematology Oncology, Medicine, Duke University, 1993 - 1996
Medical Resident, Medicine, University of Washington, 1990 - 1993
M.D., Yale University, 1990

About The Presentors

Andrea (Andi) Dwyer

andi_dwyer_dir_health_promotionAndrea (Andi) Dwyer is the Co-Director of the Colorado Colorectal Screening Program at the University of Colorado Cancer Center and Program Director at the Colorado School of Public Health. Andi was a key member of the team who developed and implemented patient navigation of the Colorado Colorectal Screening Program (the Program), one of the largest screening and early detection navigation programs in the country.

She has worked for nearly ten years in the area of colorectal cancer prevention and health promotion and authored several papers in the field. Andi is also an instructor for the Colorado Patient Navigation Training. She serves as the Project Director for the Colorado Cancer Prevention and Control Research Network, jointly funded by Centers for Disease Control and Prevention (CDC) and National Cancer Institute (NCI) and is working in the area of dissemination and implementation research.  Andi is the out-going chair of the Colorado Colorectal Task Force and Co-Chair of Scientific and Evidence Based Health Interventions of the National Colorectal Cancer Roundtable.

She also serves as the Director of Health Promotion for Fight Colorectal Cancer, focusing on research and patient education.